Sherwin-Williams stock has delivered a 26.6% gain over the past three years, yet current checks describe the shares as fairly valued on an intrinsic value basis while traditional multiples flag the stock as expensive. That mix leaves Sherwin-Williams looking neither clearly cheap nor obviously overvalued at today’s US$338.81 close.
The issue now is whether Sherwin-Williams at this price offers enough long term intrinsic value to justify paying what looks like a full market multiple today.
Compare Sherwin-Williams with a curated set of stocks that pair quality with more attractive entry points through the 45 high quality undervalued stocks
The Discounted Cash Flow (DCF) model values Sherwin-Williams on the cash it is expected to generate for shareholders over time. The latest twelve month free cash flow sits at about US$3.0b, and the model assumes this cash flow keeps growing rather than shrinking, but at a measured pace that fits a mature business.
On these assumptions, the DCF points to an estimated intrinsic value of about $360 per share, slightly above the current $338.81 price. That gap implies around a 6.0% discount to the model’s estimate, which is modest rather than a deep value signal. Sherwin-Williams therefore screens as mildly cheap on a cash flow basis, with the model essentially saying that today’s buyer is paying close to what the projected cash flows support.
On this DCF view, Sherwin-Williams looks roughly fairly valued, with only a small margin between price and estimated intrinsic value.
Sherwin-Williams is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.
The P/E ratio is a useful cross check for Sherwin-Williams because earnings are a key driver for a mature, consistently profitable business. At about 30.4x earnings, Sherwin-Williams trades at a visibly higher multiple than the broader chemicals industry average near 23.7x, and also above the peer group average of about 22.5x. That already signals investors are paying a premium price for each dollar of current earnings.
The fair P/E ratio from the model is 21.5x, which reflects what investors might typically pay for Sherwin-Williams given its sector, margins, size and risk profile. The current 30.4x level sits well above that fair ratio, so the stock screens as expensive on this earnings yardstick even before considering any company specific strengths or risks.
On the P/E multiple, Sherwin-Williams stock appears overvalued relative to both tailored and industry benchmarks.
See what the numbers say about this price — find out in our valuation breakdown.
Sherwin-Williams Narratives on Simply Wall St pick up where this valuation puzzle leaves off and outline which future paths for growth, margins and earnings would need to occur for the stock to be worth materially more or less than today’s price. Each idea is framed as a thesis about Sherwin-Williams' business that can be revisited over time, rather than a one-off snapshot, and they are available on the company’s Community page.
One of the top community narratives on Sherwin-Williams: roughly fairly valued
"Rising tariffs and flat raw material costs threaten gross margins, potentially compressing earnings without compensatory revenue growth…"
Read one of the top narratives on Sherwin-Williams
Do you think there's more to the story for Sherwin-Williams? Head over to our Community to see what others are saying!
Sherwin-Williams looks roughly fairly priced on Discounted Cash Flow, with the intrinsic value estimate only modestly above the current share price. The P/E view is less forgiving and points to an overvalued stock relative to both peers and a tailored fair ratio. That split mainly reflects cash flow strength on one side and elevated growth expectations and sentiment on the other. The key question from here is whether Sherwin-Williams can sustain the earnings quality and pricing power that would keep investors comfortable paying a premium multiple.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com